Skip navigation

Sigma-Aldrich Corp.

NAS : SIAL
Pharmaceuticals
St. Louis MO
2013 Revenue (US$ Millions)$2,704
2012 Revenue (US$ Millions)$2,623
Revenue Growth (%)3.09%
Net Income (US$ Millions)$491
Common Shares Outstanding (Millions)$119
Earnings Per Share (US$)$4.06
Price To Earnings Ratio94.19
Total Equity (US$ Millions)$2,895
Profit Margin (%)18.16%
Return On Equity (%)19.29%
Long Term Debt (US$ Millions)$300
Debt To Equity Ratio (%)0.10%
Market Capitalization (US$ Millions)$11,187
Total Assets (US$ Millions)$3,805
Return on Assets (%)12.85
Current Assets (US$ Millions)$1,921
Inventories (US$ Millions)$699
Current Liabilities (US$ Millions)$383
Cost of Goods Sold (US$ Millions)$1,343
Asset Turnover0.71
Inventory Turnover1.89
ExchangeNAS